HER2CLIMB-05 trial evaluated Tukysa in combination with Herceptin and Perjeta for HER2-positive metastatic breast cancer, ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

Dave Coulier sat down for an interview with CURE to discuss his recent tongue cancer diagnosis and his treatment journey.

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

There are two trials that I think are probably the most excited about. One of them is called the PEAK trial, and it was a ...

Let Go and Let God. I ask God to give me and my wife strength, peace and serenity to go through this journey, especially at ...

Ceremony completes my trio of words. This past year, I've become a vessel for ritual moments that transform ordinary spaces ...

She recently delivered the keynote address at the inaugural Blood Cancer Heroes celebration, held in partnership with Blood ...

The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy ...

In reflecting on their journeys, multiple myeloma care partners share crucial insights they wish they’d known sooner.

Care partners for multiple myeloma patients emphasize that managing their own mental health is not a luxury, but a necessity ...